[ Price : $8.95]
Members of FDAs Antiviral Drugs Advisory Committee unanimously recommend approval of Janssens simeprevir in treating some cases of...[ Price : $8.95]
NPS Pharmaceuticals submits a BLA for Natpara (recombinant human parathyroid hormone 1-84, rhPTH).[ Price : $8.95]
The CDER Nanotechnology Risk Assessment Working Group says increased nanotechnology regulatory science research and up-to-date tra...[ Price : $8.95]
FDA grants Alexion Pharma International a Breakthrough Therapy designation for its cyclic pyranopterin monophosphate, an enzyme co...[ Price : $8.95]
Researchers suggest four models that could accommodate increased calls for greater sharing of clinical trial data.[ Price : $8.95]
FDA grants Merck a breakthrough therapy designation for MK-5172/MK-8742 for treating chronic hepatitis C virus infection.[ Price : $8.95]
Federal Register Notice: FDAs Pediatric Oncology Subcommittee will meet 11/4 to discuss FDAs position on patient-reported outcomes...[ Price : $8.95]
Federal Register Notice: FDAs Pediatric Oncology Subcommittee will meet 11/5 to the development of three products for potential pe...